Effect of amino acid on blood glucose level when carbohydrate ingestio
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000030579
- Lead Sponsor
- Medical Corporation Hokubukai Utsukushigaoka Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 13
Not provided
1) A person with serious medical history and surgical obstacles. 2) A person who has medical disorders in heart, liver, kidney, etc. being treated during screening (including cases of complications of other diseases). 3) A person who currently has a history of gastrointestinal disorders, or who has a history of digestive surgery with problems with digestive absorption. 4) A person who is evaluated as diabetes or borderline at the time of screening (according to the criteria specified in the Diabetes Treatment Guide 2016 - 2017. Japan Diabetes Association). 5) A person who donated more than 200 mL as component donation or whole blood from 4 weeks before the start of the study until the start of the study. A person who donated 400 mL of whole blood from 4 months before the start of the test, whose blood collection amount over 1200mL within 12 months when add the planned total blood collection amount of this study. 6) A person who has participated in other clinical study and monitor test or are planned to participate in other clinical study. 7) A person who drinks alcohol over 60g/day or smokes cigarets. 8) A person who does not eat meals regularly. A person who is not a shift worker. 9) A person who regularly uses medicines, specified health foods, functional foods, health foods etc. 10) A person who got sick by blood collection in the past. 11) A person who has difficulty in blood collection because blood vessels are hard to see. 12) A person who is judged to be inappropriate for current study based on the medical chart by medical doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose level
- Secondary Outcome Measures
Name Time Method Blood insulin level Blood glucagon level